According to Renub Research United States Human Growth Hormone (HGH) market is positioned for robust expansion over the forecast period, driven by increasing diagnosis rates of hormone-related disorders, technological progress in recombinant biotechnology, and rising healthcare expenditure. The market, valued at approximately US$ 2.12 billion in 2025, is projected to reach around US$ 4.45 billion by 2034, registering a strong compound annual growth rate (CAGR) of 8.56% from 2026 to 2034. This sustained growth reflects the widening clinical adoption of HGH across pediatric and adult indications, alongside growing interest in hormone optimization and personalized medicine within regulated medical frameworks.
United States Human Growth Hormone Market OutlookHuman Growth Hormone, also known as somatotropin, is a peptide hormone natura…